The 20 Best Cervical Cancer Doctors Near Me in Ann Arbor, MI

Dr. Uppal is a board-certified Gynecologic Oncologist and Division Chief for the Gynecology Oncology service at the University of Michigan. He is also the Director of Gynecologic Oncology Initiatives at the Michigan Oncology Quality Consortium (MOQC) - a statewide quality improvement network. Dr. Uppal received his medical degree from the All India Institute of Medical Sciences (AIIMS) in New Delhi, India. He completed his Obstetrics and Gynecology residency at Temple University Hospital in Philadelphia and a fellowship in Gynecology Oncology at the University of Wisconsin in Madison, Wisconsin. He joined the faculty of the University of Michigan in 2014. Dr. Uppal also holds a Master in Business Administration (MBA) from the University of the Michigan Stephen M. Ross School of Business.Dr. Uppal has been in clinical practice for over ten years and is involved in many Quality Improvement Projects in the Division of Gynecologic Oncology, nationally and across Michigan. Widely acknowledged as a thought leader in Gynecology Oncology and quality-of-care, he has authored over 75 peer-reviewed manuscripts and instituted changes in the health system to improve outcomes after surgery, reduce the cost of care and implemented patient-centered care delivery systems. Dr. Uppal is rated as a Distinguished provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Oophorectomy. Dr. Uppal is board certified in Gynecologic Oncology and Obstetrics & Gynecology.

Dr. Hansen is a graduate of the University of Michigan. She then completed her medical degree at the Kirksville College of Osteopathic Medicine and residency training at the University of Iowa Hospitals and Clinics. She completed her gynecologic oncology fellowship at MD Anderson Cancer Center. She joined the faculty as an assistant professor in 2018. She serves on national committees for both the Society of Gynecologic Oncology and NRG Oncology. She is the principal investigator for Gynecologic Oncology Group (GOG) and industry-sponsored clinical research trials available at the University of Michigan. Dr. Siedel is rated as a Distinguished provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor.

Dr. Lieberman is a Clinical Professor of Obstetrics & Gynecology and Pathology. Dr. Lieberman received a BA from Wittenberg University in Springfield, Ohio and an M.D. from The Uniform Services, University of Health Sciences in Bethesda, Maryland. He completed an internship and residency training in Obstetrics and Gynecology at the United States Air Force Medical Center, Keesler Airforce Base (Mississippi). Following an overseas tour of duty with the USAF, in 1990 he initiated residency training in Anatomic Pathology at the National Naval Medical Center in Bethesda, Maryland and subsequently completed a Fellowship in Gynecologic Pathology at the Armed Forces Institute of Pathology in Washington, D.C.Dr. Lieberman served as a physician with the U.S. Air Force, Medical Corps from 1979-1996. During this period he served as Chief of Obstetrics & Gynecology at RAF Upper Heyford in the United Kingdom, was appointed Adjunct Clinical Instructor of Pathology and Assistant Professor of Pathology at the Uniformed Services of Health Sciences in Bethesda. Upon retirement from the U.S. Air Force, Dr. Lieberman joined the faculty at the University of Michigan Medical School as Clinical Assistant Professor in the Departments of Pathology and Obstetrics and Gynecology in 1997.Dr. Lieberman is board certified in Obstetrics and Gynecology and Anatomic Pathology. Dr. Lieberman is rated as an Advanced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Cervical Dysplasia, Human Papillomavirus Infection, Vaginal Cancer, and Bowenoid Papulosis. Dr. Lieberman is board certified in Pathology-Anatomic, Obstetrics & Gynecology, and Anatomic & Clinical Pathology.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Advanced provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Melissa Brackmann, MD is an Assistant Professor of Gynecologic Oncology at the University of Michigan Medical School.Dr. Brackmann graduated from the University of Michigan with a degree in Cellular and Molecular Biology. She received her medical degree from Harvard Medical School in 2013 and completed residency in OBGYN at Michigan Medicine in 2017, followed by fellowship in Gynecologic Oncology at Michigan Medicine in 2020. She was faculty at the University of Utah from 2020 to 2023, where she served as the Associate Residency Program Director for the OBGYN residency program and Director of the Core Sub-Internship in Gynecologic Oncology. She returned to Michigan Medicine as an Assistant Professor in 2023.Dr. Brackmann's clinical interests include the surgical and medical management of gynecologic cancers, placenta accreta spectrum, minimally invasive surgical techniques and patient/family education.Dr. Brackmann's research interests include post-graduate medical education, surgical simulation and quality improvement.Outside of medicine, Dr. Brackmann enjoys spending time with friends and family and watching college football. Dr. Brackmann is rated as an Advanced provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor. Dr. Brackmann is board certified in Obstetrics & Gynecology and Gynecologic Oncology.

Stefany Acosta is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Acosta is rated as an Advanced provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Cervical Cancer, and Splenectomy. Dr. Acosta is board certified in Obstetrics & Gynecology and Gynecologic Oncology.

James Shields is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Shields is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Intussusception in Children, Retroperitoneal Fibrosis, Cerebral Arteriovenous Malformation, Urothelial Cancer, and Gastrostomy.

Dr. Harper completed her medical school and residency trainings at the University of Kansas in Kansas City Kansas. She founded the Gynecologic Cancer Prevention Research Group while at Geisel school of medicine at Dartmouth which conducted clinical trials translating biologic, immunologic, physics and engineering properties into improved screening methods and prevention strategies for cervical cancer. Having been a member of the United States Preventive Services Task Force, she provides guidance on evidence based cost effective strategies for keeping populations healthy. She specializes in multidisciplinary collaborations for both her scientific research and for her patient care. Dr. Harper is rated as a Distinguished provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Human Papillomavirus Infection, Cervical Dysplasia, Endoscopy, and Hysterectomy.

Sahira Kazanjian is a Radiologist and an Interventional Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Kazanjian is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Ascites, Retroperitoneal Fibrosis, Intussusception in Children, Thrombectomy, and Bone Marrow Aspiration. Dr. Kazanjian is board certified in Interventional Radiology & Diagnostic Radiology.

Dr Warhadpande completed his surgical internship and radiology residency at University of Pittsburgh Medical Center (UPMC), where he served as the Chief Resident in his final year. He went on to complete his Vascular and Interventional Radiology (VIR) training at the Medical College of Wisconsin – one of the most decorated and clinical VIR training programs in the country.During his training, Dr Warhadpande was heavily involved in the Society of Interventional Radiology (SIR) and served as the Governing Council Chair of the Resident/Fellow Section. He has published over 20 manuscripts in various journals and has presented at numerous national IR meetings. He is also the co-editor and co-author of one of the best-selling textbooks in interventional radiology, The Pocketbook of Clinical IR: A Concise Guide to Interventional Radiology. At the University of Michigan, Dr Warhadpande has taken a keen interest in providing minimally-invasive pain interventions in the oncologic and non-oncologic patient populations. This includes nerve ablations, soft tissue lesion cryoablations, and bony lesion radiofrequency ablation and cementoplasty.From an endovascular standpoint, Dr Warhadpande’s expertise and research interest is in providing embolotherapy. This is a new frontier in medicine and Dr Warhadpande offers Prostate Artery Embolization (PAE) for Benign Prostatic Hyperplasia, Geniculate Artery Embolization (GAE) for knee osteoarthritis, and Uterine Fibroid Embolization (UFE) for fibroids. Dr. Warhadpande is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Retroperitoneal Fibrosis, Intussusception in Children, Adrenocortical Carcinoma, Gastrostomy, and Vertebroplasty. Dr. Warhadpande is board certified in Interventional Radiology & Diagnostic Radiology.

Dr. William M. Sherk is a board-certified Vascular Interventional Radiologist specializing in venous, lymphatic, and aortic diseases. He is co-lead of the steering committee of the Frankel Cardiovascular Center Venous Health Program, a multidisciplinary team focusing on the care of patients with complex venous problems. Dr. Sherk completed training at the University of Michigan in Interventional Radiology, where he served as Chief Resident. After residency, he joined the faculty at University of Michigan in the division of Interventional Radiology. His research focuses on the diagnosis and multidisciplinary treatments of venous disease, including chronic venous occlusion, cancer-related venous obstruction, and pulmonary embolism. He currently serves as the Program Director for the Integrated Interventional Radiology residency. Dr. Sherk is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Retroperitoneal Fibrosis, Intussusception in Children, May Thurner Syndrome, SVC Obstruction, and Thrombectomy. Dr. Sherk is board certified in Interventional Radiology & Diagnostic Radiology.

Medical school: Creighton University School of Medicine; Internship: University of Michigan Hospitals- Pediatrics/Internal Medicine; Residency: University of Cleveland Hospitals- Radiation Oncology. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Breast Cancer. Dr. Kane is board certified in Radiation Oncology.

Dr. Saunders is a board-certified gynecologist with a comprehensive focus on women’s health across all stages of life. With extensive experience in general gynecology, she provides compassionate, evidence-based care for a wide range of reproductive health concerns.She has a particular clinical interest and advanced training in the diagnosis and management of vulvar diseases, offering thoughtful, individualized care for conditions that are often underdiagnosed and misunderstood. Dr. Saunders is also deeply committed to guiding patients through the transitional phases of perimenopause and menopause, helping them navigate hormonal changes with expertise and empathy.Known for her attentive listening and patient-centered approach, Dr. Saunders partners with each patient to develop care plans that reflect their personal goals, values, and health needs. Whether managing routine gynecologic care or addressing more complex conditions, she strives to create a safe, supportive environment where every patient feels heard and respected.Outside of the clinic, Dr. Saunders enjoys staying active through regular exercise and exploring new places through travel. Most of all, Dr. Saunders values quality time with family and friends, believing that meaningful relationships are key to a well-rounded life. Dr. Saunders is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Lichen Sclerosus, Vulvodynia, Vitiligo, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT). Dr. Saunders is board certified in Obstetrics & Gynecology.

R Reynolds is an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Reynolds is rated as an Advanced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Endometrial Cancer, Hysterectomy, and Hernia Surgery.

Zhen Zhou is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Ann Arbor, Michigan. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Hysterectomy, and Intrauterine Device Insertion. Dr. Zhou is board certified in Gynecologic Oncology and Obstetrics & Gynecology.

Christopher Lao is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lao is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Metastatic Uveal Melanoma.

Dr. Lawrence is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Michigan Medical School.Dr. Lawrence received her undergraduate degree at UNC -Chapel Hill before completing medical school, OBGYN residency, and a Fellowship in Global Women's Health at the University of Michigan.Dr. Lawrence was OBGYN Administrative Chief Resident 2018-2019. She won a number of teaching awards, including the Award for Excellence in Intern Education, the Galen's Society Bronze Beeper Award for excellence in medical student teaching (2016, 2017, 2019), and the Outstanding Educator Award for resident education of medical students. Dr. Lawrence is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Eclampsia, Preeclampsia, HELLP Syndrome, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Stroumsa is a Clinical Lecturer in the Department of Obstetrics and Gynecology at the University of Michigan.Dr. Stroumsa received their medical education at the Hebrew University / Hadassah Medical School in Jerusalem. Dr. Stroumsa also completed a post-doctoral fellowship in health services research (2017-2019), through the National Clinician Scholars Program at the University of Michigan. During the fellowship, Dr. Stroumsa gained expertise in the healthcare needs of transgender and non-binary people. Dr. Stroumsa is rated as an Experienced provider by MediFind in the treatment of Cervical Cancer. Her clinical expertise encompasses Human Papillomavirus Infection, Infertility, Cervical Cancer, Vaginal Bleeding Between Periods, and Hormone Replacement Therapy (HRT). Dr. Stroumsa is board certified in Obstetrics & Gynecology.